GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » PB Ratio

Oncimmune Holdings (LSE:ONC) PB Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-05), Oncimmune Holdings's share price is £0.1785. Oncimmune Holdings's Book Value per Share for the quarter that ended in Feb. 2024 was £-0.02. Hence, Oncimmune Holdings's PB Ratio of today is .

The historical rank and industry rank for Oncimmune Holdings's PB Ratio or its related term are showing as below:

During the past 12 years, Oncimmune Holdings's highest PB Ratio was 30.67. The lowest was 2.58. And the median was 7.78.

LSE:ONC's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.535
* Ranked among companies with meaningful PB Ratio only.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Oncimmune Holdings was -13.40% per year. The lowest was -29.80% per year. And the median was -21.60% per year.

Back to Basics: PB Ratio


Oncimmune Holdings PB Ratio Historical Data

The historical data trend for Oncimmune Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings PB Ratio Chart

Oncimmune Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 Aug23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.46 - 27.43 - 25.78

Oncimmune Holdings Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.72 - - 25.78 -

Competitive Comparison of Oncimmune Holdings's PB Ratio

For the Biotechnology subindustry, Oncimmune Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncimmune Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's PB Ratio falls into.



Oncimmune Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Oncimmune Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Feb. 2024)
=0.1785/-0.017
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Oncimmune Holdings  (LSE:ONC) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Oncimmune Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncimmune Holdings (LSE:ONC) Business Description

Traded in Other Exchanges
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.

Oncimmune Holdings (LSE:ONC) Headlines

No Headlines